Pfizer Inc (PFE)

$25.33 -0.44 (-1.71%)
Market Cap 148.00B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 8.03
Forward PE 8.09
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 43,435,481
Avg Vol 73,117,133
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 63%
Beta 0.46
Analysts Sell
Price Target $28.32

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Turbofueled
Turbofueled Dec. 9 at 11:38 PM
$LEXX $LEXX is going to be the make it or break it for these Big Pharmas pill form…… Better come to the table things are gonna explode at $LEXX 🌋🌋 “As is typical for the GLP-1 drug class, the most frequent adverse events were gastrointestinal -- nausea and vomiting being the two most common side effects during the titration phase.” $GPCR $NVO $LLY $PFE https://www.techtarget.com/pharmalifesciences/news/366636177/Structure-announces-mid-phase-data-for-its-oral-GLP-1-candidate
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 9 at 11:04 PM
$MRNA $PFE $NVAX $SPY
0 · Reply
hegdaom
hegdaom Dec. 9 at 9:47 PM
$CAPR $PFE
0 · Reply
scor0328
scor0328 Dec. 9 at 9:34 PM
$CAPR $PFE seems so desperate to buy growth, paying up and throwing darts at GLP 1 market. Buy the time they enter, the GLPs will be a commodity. Meanwhile you would think Bourla would be knocking on the door in San Diego for a P3 proven dmd treatment, esp after their failures.
3 · Reply
LeftyT
LeftyT Dec. 9 at 9:19 PM
$ALT Competition update: Pfizer $PFE is being penny wise and pound foolish w/ their Yao Pharma licensing deal. It's a $1.9 B biobucks deal w/ $150 M cash up front, which was critical as Yao didn't have enough cash to finish their ongoing P1 trial. All that for another GLP-1 agonist, all that because they're too cheap to buy out ALT for $4 b and get a P3 ready product. This is on top of their recent purchase of Metsera, after a bidding war w/ Novo Nordisk $NVO , to get yet another GLP-1 drug still in P2b testing. Not sure who's calling the shots on this at Pfizer, but the shotgun accuracy is costing them more than it should. https://www.fiercebiotech.com/biotech/pfizer-continues-renewed-obesity-push-2b-pact-fosun-units-glp-1-drug
2 · Reply
HedgeAlerts
HedgeAlerts Dec. 9 at 9:14 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PFE $25.50 Put · DEC 19, 2025 Exp Entry Price: $0.46 - $0.47 Exit Price Target: $0.64 Profit Margin: +40% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Willieberich
Willieberich Dec. 9 at 9:12 PM
$PFE I'm being forced to buy here again..10,000 is coming quickly..
0 · Reply
SeriouslyWhy
SeriouslyWhy Dec. 9 at 9:11 PM
$PFE wow what a pos
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Dec. 9 at 9:06 PM
$PFE Well the good news is the market closed on time
1 · Reply
10dollarput
10dollarput Dec. 9 at 9:05 PM
$PFE This guy fucked us by selling today.
0 · Reply
Latest News on PFE
Down 50%, Should You Buy the Dip on Pfizer?

Dec 9, 2025, 4:15 PM EST - 2 hours ago

Down 50%, Should You Buy the Dip on Pfizer?

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Dec 9, 2025, 3:30 PM EST - 3 hours ago

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Dec 9, 2025, 11:14 AM EST - 7 hours ago

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Dec 9, 2025, 10:59 AM EST - 7 hours ago

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains

Dec 9, 2025, 10:45 AM EST - 8 hours ago

Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

Dec 9, 2025, 10:15 AM EST - 8 hours ago

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

AES AMCR ARE CAG CPB D DOC

Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

Dec 9, 2025, 6:55 AM EST - 11 hours ago

Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

Pfizer partners with YaoPharma for weight management treatment

Dec 9, 2025, 6:38 AM EST - 12 hours ago

Pfizer partners with YaoPharma for weight management treatment

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

Dec 9, 2025, 6:30 AM EST - 12 hours ago

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

Dec 6, 2025, 5:15 PM EST - 3 days ago

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

Do These 3 Healthcare Stocks Need a Checkup?

Dec 5, 2025, 4:05 PM EST - 4 days ago

Do These 3 Healthcare Stocks Need a Checkup?

BMY MRK

2 Headwinds Facing Pfizer Stock Going Into 2026

Dec 5, 2025, 10:05 AM EST - 4 days ago

2 Headwinds Facing Pfizer Stock Going Into 2026

Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 4 days ago

Pfizer: The Market Is Still Wrong About It

17 dividend-stock bargains from a value manager with a stellar track record

Dec 2, 2025, 12:11 PM EST - 7 days ago

17 dividend-stock bargains from a value manager with a stellar track record

BMY CIVI CMCSA CVS MOS MRK MTH

2 Top Dividend Stocks to Buy Now and Hold For a Decade

Dec 2, 2025, 7:44 AM EST - 7 days ago

2 Top Dividend Stocks to Buy Now and Hold For a Decade

ABBV

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 8 days ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA NVAX

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 8 days ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA NVAX

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

Dec 1, 2025, 10:00 AM EST - 8 days ago

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

2 Undervalued, High-Quality Companies to Buy Now and Hold Forever

Nov 30, 2025, 9:05 PM EST - 8 days ago

2 Undervalued, High-Quality Companies to Buy Now and Hold Forever

BMY

This 7% Yielder Could Be a Top AI Play

Nov 30, 2025, 4:04 PM EST - 9 days ago

This 7% Yielder Could Be a Top AI Play

3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio

Nov 30, 2025, 6:30 AM EST - 9 days ago

3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio

JNJ MDT

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Nov 30, 2025, 6:13 AM EST - 9 days ago

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

Nov 29, 2025, 11:59 PM EST - 9 days ago

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

MA AVGO

8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills

Nov 28, 2025, 11:00 AM EST - 11 days ago

8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills

BBB BBY BMY CAG EQR KEY KIM

8 Dividend Stocks Every Investor Should Consider

Nov 28, 2025, 5:30 AM EST - 11 days ago

8 Dividend Stocks Every Investor Should Consider

ABBV AXP COST JPM NVDA PM SPGI

Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years

Nov 27, 2025, 4:01 AM EST - 12 days ago

Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years

HD JNJ O

Final Trade: DAL, AXP, PFE, HMY

Nov 26, 2025, 6:20 PM EST - 13 days ago

Final Trade: DAL, AXP, PFE, HMY

AXP DAL HMY

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

Nov 26, 2025, 12:30 PM EST - 13 days ago

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

VALN

Did Pfizer Just Say "Checkmate" to Novo Nordisk?

Nov 26, 2025, 4:15 AM EST - 13 days ago

Did Pfizer Just Say "Checkmate" to Novo Nordisk?

Is This the Best Value Stock to Buy While Markets Are Volatile?

Nov 25, 2025, 6:24 AM EST - 14 days ago

Is This the Best Value Stock to Buy While Markets Are Volatile?

Want Over $7,000 in Annual Dividends? Invest $25,000 in Each of These 4 Stocks.

Nov 25, 2025, 5:30 AM EST - 14 days ago

Want Over $7,000 in Annual Dividends? Invest $25,000 in Each of These 4 Stocks.

CAG UPS VZ

JNJ Stock vs. PFE Stock: Which Pharmaceutical Giant Is A Better Buy?

Nov 25, 2025, 5:20 AM EST - 14 days ago

JNJ Stock vs. PFE Stock: Which Pharmaceutical Giant Is A Better Buy?

JNJ

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon

Nov 22, 2025, 9:20 AM EST - 17 days ago

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon

VKTX

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Nov 21, 2025, 1:24 PM EST - 18 days ago

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

This 7%-Yielding Dividend Stock Is About to Enter an Exciting New Phase

Nov 21, 2025, 8:00 AM EST - 18 days ago

This 7%-Yielding Dividend Stock Is About to Enter an Exciting New Phase

Pfizer Crosses Below Key Moving Average Level

Nov 20, 2025, 4:05 PM EST - 19 days ago

Pfizer Crosses Below Key Moving Average Level

$100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend Yield

Nov 20, 2025, 11:17 AM EST - 19 days ago

$100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend Yield

AMGN BMY GILD IVV MRK SPY VOO

Is Pfizer's 6.9%-Yielding Dividend Still Safe?

Nov 20, 2025, 9:30 AM EST - 19 days ago

Is Pfizer's 6.9%-Yielding Dividend Still Safe?

October Readers Identified 10 Ideal "Safer" Dividends In 39 Dogs

Nov 19, 2025, 5:43 PM EST - 20 days ago

October Readers Identified 10 Ideal "Safer" Dividends In 39 Dogs

CAG CIM EPD HAFN HRL IPG KEY

Pfizer: Is This Pharma Giant Finally A Bargain

Nov 19, 2025, 3:51 PM EST - 20 days ago

Pfizer: Is This Pharma Giant Finally A Bargain

Pfizer in $41.5 million settlement with Texas over ADHD drug

Nov 19, 2025, 10:31 AM EST - 20 days ago

Pfizer in $41.5 million settlement with Texas over ADHD drug

Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 19, 2025, 6:58 AM EST - 20 days ago

Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

Nov 18, 2025, 4:21 PM EST - 21 days ago

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

AZN JNJ LLY MDT MRK NVO OLMA

Global drugmakers rush to boost US presence as tariff threat looms

Nov 18, 2025, 8:25 AM EST - 21 days ago

Global drugmakers rush to boost US presence as tariff threat looms

ABBV AMGN AZN BIIB GILD GSK JNJ

2 No-Brainer Healthcare Stocks to Buy Now

Nov 18, 2025, 6:45 AM EST - 21 days ago

2 No-Brainer Healthcare Stocks to Buy Now

VKTX

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?

Nov 17, 2025, 9:10 PM EST - 21 days ago

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?

US-Saudi event to include CEOs from Chevron, Qualcomm, Pfizer, source says

Nov 17, 2025, 6:54 PM EST - 21 days ago

US-Saudi event to include CEOs from Chevron, Qualcomm, Pfizer, source says

CVX QCOM CSCO GD

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

Nov 17, 2025, 4:05 PM EST - 22 days ago

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

INCY PPH VRTX XBI XLV

2 Giant Healthcare Stocks to Buy Hand Over Fist in November

Nov 17, 2025, 10:00 AM EST - 22 days ago

2 Giant Healthcare Stocks to Buy Hand Over Fist in November

MDT

Down 55%, Should You Buy the Dip on Pfizer?

Nov 17, 2025, 4:35 AM EST - 22 days ago

Down 55%, Should You Buy the Dip on Pfizer?

Turbofueled
Turbofueled Dec. 9 at 11:38 PM
$LEXX $LEXX is going to be the make it or break it for these Big Pharmas pill form…… Better come to the table things are gonna explode at $LEXX 🌋🌋 “As is typical for the GLP-1 drug class, the most frequent adverse events were gastrointestinal -- nausea and vomiting being the two most common side effects during the titration phase.” $GPCR $NVO $LLY $PFE https://www.techtarget.com/pharmalifesciences/news/366636177/Structure-announces-mid-phase-data-for-its-oral-GLP-1-candidate
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 9 at 11:04 PM
$MRNA $PFE $NVAX $SPY
0 · Reply
hegdaom
hegdaom Dec. 9 at 9:47 PM
$CAPR $PFE
0 · Reply
scor0328
scor0328 Dec. 9 at 9:34 PM
$CAPR $PFE seems so desperate to buy growth, paying up and throwing darts at GLP 1 market. Buy the time they enter, the GLPs will be a commodity. Meanwhile you would think Bourla would be knocking on the door in San Diego for a P3 proven dmd treatment, esp after their failures.
3 · Reply
LeftyT
LeftyT Dec. 9 at 9:19 PM
$ALT Competition update: Pfizer $PFE is being penny wise and pound foolish w/ their Yao Pharma licensing deal. It's a $1.9 B biobucks deal w/ $150 M cash up front, which was critical as Yao didn't have enough cash to finish their ongoing P1 trial. All that for another GLP-1 agonist, all that because they're too cheap to buy out ALT for $4 b and get a P3 ready product. This is on top of their recent purchase of Metsera, after a bidding war w/ Novo Nordisk $NVO , to get yet another GLP-1 drug still in P2b testing. Not sure who's calling the shots on this at Pfizer, but the shotgun accuracy is costing them more than it should. https://www.fiercebiotech.com/biotech/pfizer-continues-renewed-obesity-push-2b-pact-fosun-units-glp-1-drug
2 · Reply
HedgeAlerts
HedgeAlerts Dec. 9 at 9:14 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PFE $25.50 Put · DEC 19, 2025 Exp Entry Price: $0.46 - $0.47 Exit Price Target: $0.64 Profit Margin: +40% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Willieberich
Willieberich Dec. 9 at 9:12 PM
$PFE I'm being forced to buy here again..10,000 is coming quickly..
0 · Reply
SeriouslyWhy
SeriouslyWhy Dec. 9 at 9:11 PM
$PFE wow what a pos
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Dec. 9 at 9:06 PM
$PFE Well the good news is the market closed on time
1 · Reply
10dollarput
10dollarput Dec. 9 at 9:05 PM
$PFE This guy fucked us by selling today.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Dec. 9 at 9:03 PM
$PFE - Well, it was a shitty day for pharma in general, so…
0 · Reply
MHM7700
MHM7700 Dec. 9 at 9:00 PM
70% gains locked in on the $PFE puts. https://stocktwits.com/MHM7700/message/638534782
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 9 at 9:00 PM
$PFE -3% from pre market high, genuinely fuck this stock
0 · Reply
Youcalledthewolf
Youcalledthewolf Dec. 9 at 8:56 PM
$PFE crazy volume at 2:05 with 250k shares. Large scale institutional trade near the bottom today.
0 · Reply
up2moon
up2moon Dec. 9 at 8:55 PM
$PFE when next pandemic strikes, Bourla will be like
0 · Reply
Ed_Ng
Ed_Ng Dec. 9 at 8:54 PM
$PFE lol this...
0 · Reply
superpiterpan
superpiterpan Dec. 9 at 8:53 PM
$PFE started a new position.
0 · Reply
BuddyBoy6975
BuddyBoy6975 Dec. 9 at 8:51 PM
$ALT $GILD $NVO $PFE $SNY Couple of stars SLOWLY aligning, with a handful still out there. Just give us the dam 48w data Jerry 🙏🙏🙏
0 · Reply
MarcoFla99
MarcoFla99 Dec. 9 at 8:51 PM
$PFE When is the BOD going to force Bourla out?
0 · Reply
BuddyBoy6975
BuddyBoy6975 Dec. 9 at 8:48 PM
$ALT $SNY $NVO $GILD $PFE Markets pricing in a Fed cut tomorrow due to sliding Economic data… Can you say Pharma launching pad….? (Yes)
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 9 at 8:47 PM
$PFE every time my account passes 100k it shits its pants… Have literally passed 100k and lost it almost 20 times in the last year
2 · Reply
LLMAgent
LLMAgent Dec. 9 at 8:43 PM
$PFE - the company locked in eternal zugzwang 😂 Any move they make just makes their position worse and stock drop
0 · Reply